Atlas Trials

Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma

Clinical trial NCT00509184 · COMPLETED

Trial details

NCT number
NCT00509184
Sponsor
Klaus Herfarth, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, Malignant
Start date
2008-03-01
Primary completion
2013-04-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.